Key result
Endocardial catheter ablation resulted in a higher rate of ventricular tachycardia recurrence in patients with non-ischemic cardiomyopathy compared to those with ischemic cardiomyopathy.
Why the study?
What are the differences in endocardial substrates and ablation outcomes for monomorphic VT between ischemic and non-ischemic cardiomyopathy?
Cohort (n=18)
No
What are the differences in endocardial substrates and ablation outcomes for monomorphic VT between ischemic and non-ischemic cardiomyopathy?
Endocardial ablation for monomorphic VT is less effective in NICM compared to ICM, likely due to the arrhythmogenic substrate being less localized to the endocardial surface in NICM.
Answers are grounded in this paper and cite their sources.
Endocardial ablation may be insufficient for VT in non-ischemic cardiomyopathy; leaves open optimal endo-epicardial strategies in prospective trials.
We investigated the differences in the endocardial substrates between ischemic cardiomyopathy (ICM) and non-ICM (NICM) by using electro-anatomical mapping and pace-mapping. We studied 18 patients (ICM and NICM, 9 each) with monomorphic ventricular tachycardia (VT) documented by 12-leads ECG. Low voltage area was defined by signal amplitude <1.5 mV. A pace-map QRS morphology that matched VT in >10 of the 12-leads ECG was regarded as a pace-map match. And conduction delay during pace-mapping was defined as the stimulus to QRS interval >or=40 ms. Low voltage area was 53.8 +/- 21.5 and 20.8 +/- 16.7 cm2 in ICM and NICM patients, respectively (P = 0.002). Pace-mapping was assessed in 6 ICM and 9 NICM. Pace-map match with conduction delay were obtained in all the 6 ICM patients. But in NICM patients, pace-map match with conduction delay was obtained in 3 patients. Pace-map match sites where conduction delay was not observed were obtained in 5 patients. Pace-map match could not be obtained in 1 patient. We attempted ablation in 6 ICM and 7 NICM patients. Subsequently, VT recurrence was not observed in ICM but it was observed in 6 of 7 NICM patients (log-rank P = 0.0016). In NICM patients, the arrhythmogenic substrate that represented the abnormal electrogram and conduction delay was observed less within the endocardial surface when compared with that observed in ICM. VT recurrence rate subsequent to endocardial ablation was higher in NICM than in ICM patients.
No takes yet. Share an insight, caveat, or question.
Fukuzawa et al. (2008) conducted a cohort in Monomorphic ventricular tachycardia in ischemic and non-ischemic cardiomyopathy (n=18). Endocardial catheter ablation vs. Ischemic cardiomyopathy (ICM) patients was evaluated on Ventricular tachycardia recurrence after ablation (p=0.0016). Endocardial catheter ablation resulted in a higher rate of ventricular tachycardia recurrence in patients with non-ischemic cardiomyopathy compared to those with ischemic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: